Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In vivo formation of mutagens by intraperitoneal administration of polycyclic aromatic hydrocarbons in animals during exposure to nitrogen dioxide.

Carcinogenesis·1996

Same author

Traumatic laceration of the intracranial vertebral artery causing fatal subarachnoid hemorrhage: case report.

Surgical neurology·1996

Same author

Traumatic subarachnoid hemorrhage as a predictable indicator of delayed ischemic symptoms.

Journal of neurosurgery·1996

Same author

Role of aspartate in ischemic spinal cord damage.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·1996

Same author

[A case of bronchiolo-alveolar carcinoma with high production of carbohydrate antigen (CA19-9)].

Nihon Geka Gakkai zasshi·1996

Same author

Ibudilast reduces intracellular calcium elevation induced by in vitro ischaemia in gerbil hippocampal slices.

Clinical and experimental pharmacology & physiology·1996

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches

Published on: May 1, 2018

Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies.

R James Christie¹, N Nishiyama, K Kataoka

¹Department of Materials Engineering, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.

|December 25, 2009

Summary

Synthetic polymers enhance nucleic acid therapies for diseases like cancer by improving stability and cellular delivery. These advanced materials overcome barriers, enabling DNA and small interfering RNA to reach targets effectively for better treatment outcomes.

More Related Videos

DNA Vector-based RNA Interference to Study Gene Function in Cancer

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Related Experiment Videos

Last Updated: Jun 17, 2026

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches

Published on: May 1, 2018

DNA Vector-based RNA Interference to Study Gene Function in Cancer

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Area of Science:

Biotechnology and Biomedical Engineering
Drug Delivery Systems
Molecular Therapy

Background:

Nucleic acid-based therapies (e.g., DNA, small interfering RNA) show promise for treating diseases like cancer by modulating protein expression.
Therapeutic efficacy is hindered by delivery challenges, including poor stability, degradation, and inefficient cellular uptake.
Overcoming these barriers requires advanced delivery vehicles to protect nucleic acids and facilitate their intracellular transport.

Purpose of the Study:

To develop and evaluate sophisticated multifunctional synthetic polymers for enhanced nucleic acid delivery.
To address limitations in nucleic acid therapy, focusing on stability, circulation time, and endosomal escape.
To create polymer-based systems that improve the therapeutic potential of DNA and small interfering RNA.

Main Methods:

Design of multifunctional synthetic polymers capable of forming ionic complexes with nucleic acids.
Incorporation of features to enhance stability in circulation and resist degradation.
Development of functionalities to promote endosome escape post-cellular internalization.

Main Results:

Synthetic polymers successfully formed stable ionic complexes with nucleic acids.
Enhanced stability in circulation and improved resistance to degradation were observed.
Demonstrated improved endosome escape capabilities, facilitating intracellular delivery of nucleic acid cargo.

Conclusions:

Multifunctional synthetic polymers represent a promising strategy for overcoming delivery barriers in nucleic acid-based therapies.
These advanced delivery systems can significantly enhance the therapeutic potential of DNA and small interfering RNA for treating diseases like cancer.
Further development of these polymer-nucleic acid complexes holds potential for next-generation molecular therapies.